CGRP-targeted therapies for migraine and the risk of infection - PubMed
2 hours ago
- #CGRP inhibitors
- #Infection risk
- #Migraine treatment
- CGRP-targeted therapies are effective for migraine management with a favorable safety profile.
- Concerns exist about infection risk due to CGRP blockade, based on real-world data and immunological studies.
- No significant increase in infections was observed in controlled clinical trials.
- Risk may be higher in patients with pre-existing immune weaknesses or multiple comorbidities.
- Ongoing monitoring and research are needed to ensure long-term safety.